Do positive pathogen antibodies with negative blood PCR indicate active infection?

Positive pathogen-specific antibodies with a negative blood PCR are a common discordant pattern whose meaning depends on pathogen, illness timing, treatment, specimen, and clinical syndrome. It is not, on its own, evidence of active infection.

Clinical interpretation

• Prior exposure or resolved infection is strongly supported. For Anaplasma phagocytophilum, IgG may remain elevated for months and occasionally up to 4 years; persistent titers do not establish active disease, treatment failure, or a need for antibiotics without compatible new illness.
• A recent or post-infectious response is also well supported. In parvovirus B19, viremia peaks earlier, while IgM appears around days 10–14 and IgG persists long term. Thus, antibody-positive/PCR-negative results can fit declining or cleared bloodstream infection.
• A single antibody result is limited evidence of timing. For anaplasmosis, paired acute and convalescent IgG IFA samples showing seroconversion or a ≥4-fold titer rise provide substantially stronger evidence for recent infection; isolated IgM is considered unreliable.

PCR timing and mechanism

• Blood PCR measures circulating pathogen nucleic acid, not immune memory. PCR sensitivity is therefore affected by sampling timing, circulating pathogen burden, and antimicrobial exposure.
• For anaplasmosis, whole-blood PCR is most useful during the first week of illness and declines rapidly—within roughly 48 hours—after appropriate antibiotics. Accordingly, a negative PCR does not rule out anaplasmosis in a clinically compatible presentation.
• Blood-negative testing can plausibly reflect infection missed in blood at that moment, but serology alone does not demonstrate persistent infection in another tissue compartment.

Bottom line

• Positive antibodies plus negative blood PCR most often supports prior exposure or a resolving/post-infectious response, and cannot by itself establish active infection. Active disease assessment requires compatible symptoms, exposure history, timing relative to illness and treatment, and appropriately selected confirmatory or repeat testing.